Stock BRNS BARINTHUS BIOTHERAPEUTICS PLC
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Barinthus Biotherapeutics plc

Equities

BRNS

US91864C1071

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-07-10 pm EDT 		5-day change 1st Jan Change
1.435 USD -0.35% Intraday chart for Barinthus Biotherapeutics plc +0.35% -61.11%
Jun. 21 Top Premarket Gainers MT
Jun. 13 Barclays Adjusts Price Target on Barinthus Biotherapeutics to $3 From $7, Maintains Overweight Rating MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
BARINTHUS BIOTHERAPEUTICS PLC Stock Barinthus Biotherapeutics plc
 56.01M - - - - -
MODERNA, INC. Stock Moderna, Inc.
 45.01B -
LONZA GROUP AG Stock Lonza Group AG
 40.96B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 38.62B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
 32.6B -
CELLTRION, INC. Stock Celltrion, Inc.
 27.49B
  1. Stock Market
  2. Equities
  3. BRNS Stock
  4. Charts Barinthus Biotherapeutics plc
  5. Sector Chart